Bridgeway Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bridgeway Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150,000	Closed	-$94K	–	1394
2022 Q1	$94K	Buy	+150,000	New	+$116K	﹤0.01%	1263
2021 Q3	–	Sell	-105,895	Closed	-$336K	–	1359
2021 Q2	$336K	Sell	105,895 -175,000	-62%	-$437K	0.01%	1186
2021 Q1	$913K	Hold	280,895	–	–	0.02%	896
2020 Q4	$176K	Hold	280,895	–	–	﹤0.01%	1226
2020 Q3	$98K	Hold	280,895	–	–	﹤0.01%	1260
2020 Q2	$152K	Buy	+280,895	New	+$136K	﹤0.01%	1188
2018 Q3	–	Sell	-862	Closed	-$49K	–	1485
2018 Q2	$49K	Sell	862 -3,846	-82%	-$140K	﹤0.01%	1392
2018 Q1	$104K	Hold	4,708	–	–	﹤0.01%	1322
2017 Q4	$118K	Hold	4,708	–	–	﹤0.01%	1319
2017 Q3	$88K	Hold	4,708	–	–	﹤0.01%	1352
2017 Q2	$43K	Sell	4,708 -33,277	-88%	-$317K	﹤0.01%	1393
2017 Q1	$598K	Buy	37,985 +23,662	+165%	+$410K	0.01%	1002
2016 Q4	$242K	Hold	14,323	–	–	﹤0.01%	1278
2016 Q3	$315K	Buy	14,323 +8,554	+148%	+$156K	﹤0.01%	1231
2016 Q2	$92K	Sell	5,769 -1,539	-21%	-$48.3K	﹤0.01%	1385
2016 Q1	$404K	Sell	7,308 -10,764	-60%	-$461K	0.01%	1129
2015 Q4	$583K	Hold	18,072	–	–	0.01%	994
2015 Q3	$531K	Hold	18,072	–	–	0.01%	996
2015 Q2	$705K	Buy	18,072 +5,769	+47%	+$266K	0.01%	920
2015 Q1	$469K	Hold	12,303	–	–	0.01%	1118
2014 Q4	$465K	Buy	12,303 +1,849	+18%	+$76.3K	0.01%	1100
2014 Q3	$593K	Buy	+10,454	New	+$563K	0.02%	996

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridgeway Capital Management's ASXC Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 150,000 shares — an estimated $94K sold.

Bridgeway Capital Management first reported a position in ASXC in Q3 2014 and held it in 22 quarters. The position peaked at $913K in Q1 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

Bridgeway Capital Management reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
Bridgeway Capital Management sold 150,000 Asensus Surgical, Inc. shares in Q2 2022, an estimated $94K.
Bridgeway Capital Management first reported a position in Asensus Surgical, Inc. in Q3 2014 and held it in 22 quarters.
Bridgeway Capital Management's Asensus Surgical, Inc. position peaked at $913K in Q1 2021.
91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.